Remote Monitored Systems’ Pharm2Farm expects to produce 2mln anti-viral face masks in February

Remote Monitored Systems said its Pharm2Farm subsidiary expects to produce a maximum of 1mln anti-viral face masks in January 2021 and 2mln in February.

The mask-making machine is now expected to be delivered on December 28 at the earliest, it added, with factory acceptance testing of the machine taking place today by manufacturer Lemu Group, to be followed by final finishing and hardening in the coming week.

Once delivery is taken by P2F’s Nottingham Biocity premises, it can begin building production towards a theoretical maximum capacity of 5mln masks per month if the machine is working 24-hours per day, seven days per week.

Pharm2farm uses a patented process for producing and functionalising nanoparticles for various applications including human, animal and crop health. Pharm2farm is a wholly owned subsidiary of Remote Monitored Systems (LON:RMS).

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Share on twitter
Share on linkedin

More articles like this

Scientists develop facemask which can kill viruses on contact

A new antiviral facemask which uses nanotechnology to kill viruses including COVID-19 and influenza has been designed and developed by a Nottingham Trent University scientist. Instead of the usual three-ply design, the five-ply surgical mask includes an additional

Global security improvement programme

Cloudveil was the appointed consultancy for the Global Security Improvement Programme for the worlds leading integrated steel and mining company. Working with a variety of stakeholders towards improving the maturity of the Global Security Function. Following a review of the Global Security Function in

Remote Monitored Systems appoints two new non-executive directors

Remote Monitored Systems plc (LON:RMS) has announced that further to the announcement on 30 December 2020, the Board has appointed two new non-executive directors; Antony Legge and Richard Clarke.  Antony Legge succeeds Paul Ryan as the Company’s Chairman,

Pioneering nano technology

Technology initially developed for the medical industry has been optimised for plant and animal nutrition. A number of trials have shown increased nutritional content through fortification, shelf life, increased nutrient use and a lower environmental footprint. The technology

Remote Monitored Systems updates on Pharm2Farm mask progress

Remote Monitored Systems plc (LON:RMS), has announced the following updates in respect of its wholly owned subsidiary, Pharm 2 Farm Limited. Receipt of new production line The Company received an update from the machine suppliers on the afternoon